Precision Immuno-Oncology in NSCLC through Gender Equity Lenses

By sjmartinez • April 14, 2024

Marks J, Sridhar A, Ai A, Kiel L, Kaufman R, Abioye O, Mantz C, Florez N. Precision Immuno-Oncology in NSCLC through Gender Equity Lenses. Cancers (Basel). 2024 Apr 4;16(7):1413. doi: 10.3390/cancers16071413. PMID: 38611091; PMCID: PMC11010825.

Tags: clinical trials, Female, General Internal Medicine, immunotherapy, NSCLC, Olive View DoM, precision oncology, Publications, underrepresentation, Women

Association of second-hand tobacco smoking with liver cancer, and interaction with HBV infection in a Chinese population-based case-control study

Liu X, Baecker A, Wu M, Zhou JY, Jin ZY, Fang F, Jung SY, Mu L, He N, Qu W, Zhang X, Li L, Zhao[...]

Primary care visit trends in a public safety net health system during the COVID-19 pandemic

Valdovinos C, Huang YC, Vassar S, Gutierrez G, Mendez C, Abhat A, Brown A, Casillas A. Primary care visit trends in a public safety net[...]

Association of Subclinical Cardiac Remodeling With Incident Cancer in the MESA Cohort

Cai X, White Q, Juarez J, Chehab O, Ambale-Venkatesh B, Johnson WC, Hansen SL, Inoue K, Lima JAC, Watson KE, McClelland RL. Association of Subclinical[...]